GOODSENSE Extra Strength — Class II drug recall D-0574-2026
Ongoing recall by Guardian Drug Co. Inc., reported 2026-06-10, distributed nationwide. Presence of foreign substance: small metallic particles in chewable tablets.
| Recall number | D-0574-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Guardian Drug Co. Inc., Dayton, NJ, United States |
| Recall initiated | 2026-05-28 |
| Classified | 2026-06-03 |
| Reported by FDA | 2026-06-10 |
| Distributed | Nationwide (US) |
| NDC | 50804-0129, 50804-0129-22 |
| Lot numbers | 1276118, 2029 |
Product
GOODSENSE Extra Strength, Antacid TABLETS, Calcium Carbonate 750 mg, 96 Chewable Tablets, Distributed by: Geiss, Destin & Dunn, inc., Peachtree City, GA, NDC 50804-129-22.
Reason for recall
Presence of foreign substance: small metallic particles in chewable tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0574-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.